Paper38256554
From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential.
Mignini I and 7 others. J Clin Med, 2024. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential. Papers, record 38256554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38256554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- From the Colon to the Liver: How Gut Microbiota May Influence Colorectal Cancer Metastatic Potential.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References132
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27876571 | Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21. | Gastroenterology | 2017 | https://conductscience.org/library/papers/27876571 | PubMed |
| 2 | 20009569 | Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/-) mice: a human commensal-based murine model of colon carcinogenesis. | Cell Cycle | 2010 | https://conductscience.org/library/papers/20009569 | PubMed |
| 3 | 33283987 | Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer. | EMBO Mol Med | 2021 | https://conductscience.org/library/papers/33283987 | PubMed |
| 4 | 25758642 | Gut microbiome development along the colorectal adenoma-carcinoma sequence. | Nat Commun | 2015 | https://conductscience.org/library/papers/25758642 | PubMed |
| 5 | 30833345 | Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β-catenin modulator Annexin A1. | EMBO Rep | 2019 | https://conductscience.org/library/papers/30833345 | PubMed |
| 6 | 18097448 | Immunological aspects of cancer chemotherapy. | Nat Rev Immunol | 2008 | https://conductscience.org/library/papers/18097448 | PubMed |
| 7 | 15554389 | Butyrate reduces liver metastasis of rat colon carcinoma cells in vivo and resistance to oxidative stress in vitro. | Clin Exp Metastasis | 2004 | https://conductscience.org/library/papers/15554389 | PubMed |
| 8 | 35887022 | Probiotic Supplementation Suppresses Tumor Growth in an Experimental Colorectal Cancer Liver Metastasis Model. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35887022 | PubMed |
| 9 | 26201900 | Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis. | Cancer Discov | 2015 | https://conductscience.org/library/papers/26201900 | PubMed |
| 10 | 32863742 | The Mechanism of Bacteroides fragilis Toxin Contributes to Colon Cancer Formation. | Malays J Med Sci | 2020 | https://conductscience.org/library/papers/32863742 | PubMed |
| 11 | 33303685 | Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. | Science | 2021 | https://conductscience.org/library/papers/33303685 | PubMed |
| 12 | 23954158 | Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. | Cell Host Microbe | 2013 | https://conductscience.org/library/papers/23954158 | PubMed |
| 13 | 37145237 | The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer. | Eur J Clin Microbiol Infect Dis | 2023 | https://conductscience.org/library/papers/37145237 | PubMed |
| 14 | 30530851 | Microbiota and cancer immunotherapy: in search of microbial signals. | Gut | 2019 | https://conductscience.org/library/papers/30530851 | PubMed |
| 15 | 37770127 | Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis. | Gut | 2023 | https://conductscience.org/library/papers/37770127 | PubMed |
| 16 | 20704571 | Survivin and IAP proteins in cell-death mechanisms. | Biochem J | 2010 | https://conductscience.org/library/papers/20704571 | PubMed |
| 17 | 23511582 | Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer. | Gut Microbes | 2013 | https://conductscience.org/library/papers/23511582 | PubMed |
| 18 | 38024475 | Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215). | EClinicalMedicine | 2023 | https://conductscience.org/library/papers/38024475 | PubMed |
| 19 | 30228205 | Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. | Cancer Immunol Res | 2018 | https://conductscience.org/library/papers/30228205 | PubMed |
| 20 | 30191984 | Fusobacterium nucleatum and colorectal cancer: A mechanistic overview. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30191984 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978490 | The Potential Role of Gut Microbiome Dysbiosis and Functional Reprogramming in Colorectal Liver Metastasis via the Gut-Liver Axis. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42978490 | PubMed |
| 42830873 | Liver Metastases from Colorectal Cancer: From Pathogenesis to Current Treatment. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42830873 | PubMed |
| 42807795 | Gastric bacterial microbiota and gastric carcinogenesis: from dysbiosis to immune remodeling and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42807795 | PubMed |
| 42795613 | From Gut Microbiota to Hepatic Pre-Metastatic Niches: Mechanism and Translational Prospects of the Gut-Liver Axis in Regulating Colorectal Cancer Liver Metastasis. | Microorganisms | 2026 | https://conductscience.org/library/papers/42795613 | PubMed |
| 42716932 | Inflammatory neuropathy in mouse and primate models of colorectal cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/42716932 | PubMed |
| 42511550 | Microenvironment-Driven Reprogramming in Colorectal Cancer Liver Metastasis: Metabolic, Phenotypic, and Immune Adaptation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42511550 | PubMed |
| 42338885 | Assessment of 16S rRNA sequencing for analysis of circulating microbial DNA in colorectal cancer patients-proof of concept and early changes during experimental chemoimmunotherapy. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42338885 | PubMed |
| 42015288 | Gut microbiota-driven pre-metastatic niche formation in colorectal cancer liver metastasis: mechanisms and translational significance. | Gut Pathog | 2026 | https://conductscience.org/library/papers/42015288 | PubMed |
| 41011853 | Investigation of Intestinal Microbiota and Short-Chain Fatty Acids in Colorectal Cancer and Detection of Biomarkers. | Pathogens | 2025 | https://conductscience.org/library/papers/41011853 | PubMed |
| 41002563 | Tumor Immune Microenvironment and Current Status of Immune Checkpoint Inhibitor Therapy in Colorectal Cancer Liver Metastasis. | Curr Oncol | 2025 | https://conductscience.org/library/papers/41002563 | PubMed |
| 40843361 | Interactions between tumor microenvironment and resistance to transarterial and systemic treatments for HCC. | Cancer Drug Resist | 2025 | https://conductscience.org/library/papers/40843361 | PubMed |
| 40297806 | The power of microbes: the key role of gut microbiota in the initiation and progression of colorectal cancer. | Front Oncol | 2025 | https://conductscience.org/library/papers/40297806 | PubMed |
| 40263747 | Metagenomics and Non-Targeted Metabolomics Reveal the Role of Gut Microbiota and Its Metabolites in Brain Metastasis of Non-Small Cell Lung Cancer. | Thorac Cancer | 2025 | https://conductscience.org/library/papers/40263747 | PubMed |
| 40110192 | Gut microbiota in colorectal cancer: a review of its influence on tumor immune surveillance and therapeutic response. | Front Oncol | 2025 | https://conductscience.org/library/papers/40110192 | PubMed |
| 39941737 | Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39941737 | PubMed |
| 39857684 | Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases. | Biomedicines | 2025 | https://conductscience.org/library/papers/39857684 | PubMed |
| 39483461 | Exploring the gut microbiome's role in colorectal cancer: diagnostic and prognostic implications. | Front Immunol | 2024 | https://conductscience.org/library/papers/39483461 | PubMed |
| 39234556 | Colorectal cancer-specific microbiome in peripheral circulation and cancer tissues. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39234556 | PubMed |
| 38890429 | Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation. | Oncogene | 2024 | https://conductscience.org/library/papers/38890429 | PubMed |
| 38791916 | Hepatocellular Carcinoma and the Multifaceted Relationship with Its Microenvironment: Attacking the Hepatocellular Carcinoma Defensive Fortress. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38791916 | PubMed |
Genes18
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38256554
GET https://conductscience.org/api/papers/v1/38256554/references?page=2